+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "RPC1063"

ZEPOSIA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ZEPOSIA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Multiple Sclerosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The RPC1063 market is a segment of the Central Nervous System (CNS) Drugs market. It is composed of drugs used to treat neurological disorders, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. These drugs are typically prescribed to improve cognitive function, reduce seizures, and improve motor control. They can also be used to treat psychiatric disorders, such as depression and anxiety. The RPC1063 market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in this market include Pfizer, Novartis, Merck, GlaxoSmithKline, Sanofi, and Johnson & Johnson. These companies are constantly developing new drugs and treatments to meet the needs of patients with neurological and psychiatric disorders. Show Less Read more